X
Gilead/Galapagos alliance hit again as IPF drug is binned
https://pharmaphorum.com/news/gilead-galapagos-alliance-hit-again-as-ipf-drug-is-binned/
respiratory disease
AstraZeneca’s respiratory biologic fails again in COPD
AstraZeneca (AZ) and MedImmune, have announced that the latest trial of Fasenra (benralizumab) in patients with moderate-to-very-severe chronic obstructive pulmonary disease (COPD) did not provide a statistically-significant reduction in exacerbations.